Skip to Main Content

Paper Details

Glycomics in rare diseases: from diagnosis tomechanism.
Transl Res
6
2019
CDGs, NIH UDP, UDP, Undiagnosed Diseases, abnormalities of N-linked and O-linked glycans, congenital disorders of glycosylation, fibroblast, glycosylation defects, human, patients, plasma, rare diseases
Author NameAffiliation
Mariska Davids
Mariska Davids
Megan S KaneMaryland Inova Translational Medicine Institute, Inova Health System
Lynne A WolfeMaryland Office of the Clinical Director, National Institutes of Health
Lynne A WolfeMaryland Office of the Clinical Director, National Institutes of Health
Camilo ToroMaryland Office of the Clinical Director, National Institutes of Health
Cynthia J TifftMaryland Office of the Clinical Director, National Institutes of Health
Cynthia J TifftMaryland Office of the Clinical Director, National Institutes of Health
David R AdamsMaryland Office of the Clinical Director, National Institutes of Health
David R AdamsMaryland Office of the Clinical Director, National Institutes of Health
Miao HeUniversity of Pennsylvania, Children's Hospital of Philadelphia
William A GahlMaryland Office of the Clinical Director, National Institutes of Health
William A GahlMaryland Office of the Clinical Director, National Institutes of Health
Cornelius F BoerkoelUniversity of British Columbia
Cornelius F BoerkoelUniversity of British Columbia
May Christine V MalicdanMaryland Office of the Clinical Director, National Institutes of Health
May Christine V MalicdanMaryland Office of the Clinical Director, National Institutes of Health
  • 1 - 17

Datasets

Release 1.2